MENU
+Compare
HCM
Stock ticker: NASDAQ
AS OF
Jun 9, 02:35 PM (EDT)
Price
$15.93
Change
+$0.58 (+3.78%)
Capitalization
2.88B

HCM HUTCHMED (China) Limited Forecast, Technical & Fundamental Analysis

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases... Show more

HCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HCM with price predictions
Jun 06, 2025

Momentum Indicator for HCM turns positive, indicating new upward trend

HCM saw its Momentum Indicator move above the 0 level on May 28, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for HCM just turned positive on May 29, 2025. Looking at past instances where HCM's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

HCM moved above its 50-day moving average on June 03, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where HCM advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for HCM crossed bearishly below the 50-day moving average on May 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HCM broke above its upper Bollinger Band on June 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for HCM entered a downward trend on May 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HCM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.918) is normal, around the industry mean (62.463). P/E Ratio (27.950) is within average values for comparable stocks, (89.614). HCM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (3.478) is also within normal values, averaging (19.198).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
HCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

HCM is expected to report earnings to fall 7,100.00% to -69 cents per share on November 11

HUTCHMED (China) Limited HCM Stock Earnings Reports
Q3'22
Est.
$-0.70
Q4'24
Missed
by $0.03
Q4'23
Beat
by $0.38
Q2'23
Beat
by $1.03
Q4'22
Est.
$-1.02
The last earnings report on March 19 showed earnings per share of 0 cents, missing the estimate of 3 cents. With 91.96K shares outstanding, the current market capitalization sits at 2.88B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals and health oriented consumer products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
2 Queen's Road Central
Phone
+852 21218200
Employees
1988
Web
https://www.hutch-med.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AVFIX22.820.31
+1.38%
American Beacon Small Cp Val R5
TCBAX8.870.08
+0.91%
Covered Bridge A
CSHAX11.350.07
+0.62%
NYLI Cushing® MLP Premier Class A
MOSLX9.750.05
+0.52%
MassMutual Overseas Adm
VEMAX40.030.15
+0.38%
Vanguard Emerging Mkts Stock Idx Adm

HCM and Stocks

Correlation & Price change

A.I.dvisor tells us that HCM and ACET have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HCM and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCM
1D Price
Change %
HCM100%
+0.59%
ACET - HCM
29%
Poorly correlated
+1.04%
CGC - HCM
26%
Poorly correlated
+24.09%
SNDL - HCM
25%
Poorly correlated
+2.33%
TLRY - HCM
25%
Poorly correlated
+4.48%
IRWD - HCM
24%
Poorly correlated
+6.58%
More